PANews reported on September 25th that according to Globenewswire, Scilex Holding Company (NASDAQ: SCLX), an innovative revenue-generating company, announced that it has completed its previously disclosed transaction pursuant to a Securities Purchase Agreement with an institutional investor, exchanging $200 million worth of common stock in its majority-owned subsidiary, Semnur Pharmaceuticals, Inc., for $200 million worth of Bitcoin. Scilex has now received the $200 million in Bitcoin into its crypto account.
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.